Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 8 of 25
Pilocarpine Microneedles for Sweat Induction (PMN-SI)
NCT04732195
Duvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS Study
NCT04890236
Electrophysiological Biomarkers in MTLE Patients.
NCT04710004
Parrying the Pitfalls of PrEP: Project PEACH
NCT05072093
Assessment of Consciousness States with NextSense Ear Bud Devices
NCT05114616
Assessment of Cloth Face Coverings as Source Control Under Laboratory and Simulated Field Conditions
NCT05216939
The Mixed Meal Challenge Study
NCT05087823
Home-Based Intervention for Chronic Pain in Adults With Sickle Cell Disease
NCT04906707
Caregiving and Racial Considerations During a Pandemic Online Training Education
NCT04732715
Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer
NCT05086731
Sleep/Wake State Assessment with Non-invasive Earbuds
NCT05066009
BEFAST (Bubble-Enhanced FAST) for the Evaluation of Solid Organ Injury
NCT05025449
Community Trial in the Cherokee Nation
NCT04839978
Producing a Fully Asynchronous Online Savvy Program
NCT04951037
Faith-Based Toolbox for African Americans With Dementia
NCT04325204
Well-child Visit Video Project
NCT05011292
Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients
NCT04862234
Savvy System Project
NCT04060355
Connecting Families to Overcome Ovarian Cancer
NCT04927013
Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer
NCT04750473
Multisite Observational Maternal and Infant Study for COVID-19
NCT05031468
Evaluating Hunger Manipulation During Feeding Intervention
NCT05053438
Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility
NCT04714216
Remote Monitoring of COVID-19 Positive Outpatients
NCT04853108
The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI
NCT04316676
SurvivorLink: Scalability of an Electronic Personal Health Record
NCT03543852
Caregiving During Crisis
NCT04939714
Cost and Shared Decision-Making for Heart Failure
NCT04793880
Effect of Citrate Dialysate on Vascular Calcification
NCT04956120
Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens
NCT04860505
Equality in Caregiving: Facilitating Caregiver Mastery Among LGBT Caregivers of PLWD
NCT04394260
Eye-Control Trial: Wearable Eye-Tracking Device as Means of Communication
NCT04582149
PROUD Study - Preventing Opioid Use Disorders
NCT04766996
Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides
NCT04676087
Dexcom Continuous Glucose Monitoring in Long-term Care
NCT04818242
Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
NCT04912895
A Pragmatic Trial of HOBSCOTCH in Georgia
NCT04639206
Biomechanical and Neural Mechanisms of Post-stroke Gait Training
NCT04380454
Telederm and Bullous Pemphigoid
NCT04728854
Effect of TMS on PTSD Biomarkers
NCT04563078
Diagnosing Intensive Care Unit (ICU) Acquired Weakness
NCT04166630
DTA (Dopaminergic Therapy for Anhedonia) Study
NCT04723147
Building Adaptive Coping and Knowledge to Improve Daily Life
NCT04602728
Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer
NCT04348292
Bacteriostatic Normal Saline Versus Lidocaine for Intradermal Anesthesia
NCT04495868
Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)
NCT04487886
Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders
NCT04556552
Efficacy of a Smoke-Free Homes Intervention
NCT04547686
Linking Persons With HIV, Discharged From Jail, With Community Care
NCT04560556
Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)
NCT04473430
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Emory University pipeline card: 1,208 registered trials from official public datasets.Report a data error.